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In vertebrates, pancreas and liver arise from bipotential progenitors located in the embryonic 
gut endoderm. BMP and FGF signalling pathways have been shown to induce hepatic 
specification while repressing pancreatic fate. Here, we show that BMP and FGF factors also 
play crucial function, at slightly later stages, in the specification of the ventral pancreas.  By 
analyzing the pancreatic markers pdx1, ptf1a and hlxb9la in different zebrafish models of 
BMP loss-of-function, we demonstrate that the BMP pathway is required between 20-24 hpf 
to specify the ventral pancreatic bud.  Knockdown experiments show that bmp2a, expressed 
in the lateral plate mesoderm at these stages, is essential for ventral pancreas specification. 
Bmp2a action is not restricted to the pancreatic domain and is also required for the proper 
expression of hepatic markers.  By contrast, through the analysis of fgf10-/-; fgf24-/- embryos, 
we unveil the specific role of these two FGF ligands in the induction of the ventral pancreas 
and in the repression of the hepatic fate. These mutants display ventral pancreas agenesis and 
ectopic masses of hepatocytes. Overall, these data highlight the dynamic role of BMP and 




Pancreas is an endodermal organ composed of endocrine and exocrine tissues that 
respectively produce hormones and digestive enzymes. During embryogenesis, pancreas 
arises from two buds developing from the dorsal and ventral aspects of the gut epithelium. 
The ventral pancreatic bud appears adjacent to the liver bud and previous studies on mouse 
embryonic explants and in zebrafish have revealed the presence of bipotential endodermal 
progenitors that can give rise to both organs (Chung et al., 2008; Deutsch et al., 2001; Rossi et 
al., 2001). This cell fate decision is controlled by extrinsic factors released by the 
neighbouring lateral plate mesoderm (LPM).  Identification of such inducing stimuli is critical 
to design novel cellular therapies for pathologies affecting these organs. 
 
In zebrafish, specification of the pancreatic region can be detected as early as 14 hours post 
fertilization (hpf) through the activation of pdx1 expression in midtrunk endoderm (Biemar et 
al., 2001).  The first pdx1 expressing cells which are located near the medial line of the 
embryo just under the notochord will delaminate to form the dorsal pancreatic bud by 24 hpf 
and will generate the first pancreatic endocrine cells.  The first signs of hepatic development 
occur at 22 hpf with the activation of prox1 and hhex expression in a segment of the gut 
endoderm anterior to the dorsal pancreatic bud (Ober et al., 2006). These prox1+/hhex+ cells 
produce an outgrowth on the left side of the intestinal rod. The formation of this hepatic bud 
is quickly followed by the specification of the ventral pancreatic bud which appears adjacent 
and posterior to the liver (Field et al., 2003a). Indeed, ptf1a and hlxb9la (also named mnr2a), 
the two earliest markers of the ventral pancreas are detected at 32 hpf between the liver and 
dorsal pancreatic buds (Wendik et al., 2004; Zecchin et al., 2004).  The pdx1 homeobox gene, 
expressed in endocrine cells of the dorsal bud, is also detected in the adjacent segment of 
intestinal rod which encompasses the prospective ventral pancreatic bud.  In zebrafish, the 
ventral pancreatic bud (VPB) generates the whole exocrine tissue comprising the acinar and 
ductal cells.  The ventral and dorsal pancreatic buds eventually merge by 52 hpf to form the 
pancreas (Field et al., 2003a; Field et al., 2003b).  
 
The ventral pancreatic and hepatic buds are induced by the adjacent mesodermal tissues 
through the release of signalling molecules such as Fibroblast Growth Factors (FGF) and 
Bone Morphogenic Proteins (BMPs).  However, conflicting data have been reported, on the 
effect of these factors, revealing either an inducing or repressing activity. For example, 
experiments on mouse embryonic explants have shown that FGF from the cardiac mesoderm 
and BMP from the septum transversum are essential for the induction of liver markers and 
block pancreatic specification (Deutsch et al., 2001; Rossi et al., 2001). Similarly, FGFs and 
BMPs have also been shown in zebrafish to be essential for hepatic induction (Shin et al., 
2007) and bmp2b can specify liver at the expense of pancreas (Chung et al., 2008).  On the 
other hand, experiments with chicken embryonic explants indicate that BMP from the LPM is 
required for development of the ventral pancreas (Kumar et al., 2003) and we have reported 
that FGF signalling is essential to specify the ventral pancreatic bud in zebrafish embryos 
(Manfroid et al., 2007). These contradictory results could be explained by a highly dynamic 
change in the inductive network. Indeed, Wandzioch et al have recently demonstrated that, 
while BMPs repress pancreatic specification at 3-4S in mouse embryos, they promote 
pancreatic fate a few hours later at 5-6S (Wandzioch and Zaret, 2009).  Another explanation 
could be that distinct members of the FGF and/or BMP ligand family have different activities. 
Thus, a better understanding of liver and ventral pancreas development will require the 
identification of the BMP and FGF ligands expressed near the prospective hepatopancreatic 
region and their mutual relation. 
 
In the present study, we show the crucial role of BMP pathway after 20 hpf for the 
specification of the ventral pancreatic bud in zebrafish embryos.  We identify bmp2a as a 
crucial player in this induction and demonstrate its requirement for the activation of the first 
markers of the ventral pancreas (ptf1a and hlxb9la) as well as of the liver (prox1 and hhex). In 
contrast, by analyzing these pancreatic and hepatic markers in the double fgf10-/-;fgf24-/- 
mutants, we find that both FGF10 and FGF24 ligands have complete opposed effect on the 
two organs, inducing all pancreatic markers while repressing hepatic markers. Thus, our study 





Requirement of BMP signalling in the specification of the ventral pancreatic bud 
 
Involvement of BMP signalling in liver bud specification has been previously investigated 
with laf/alk8 mutants (Chung et al., 2008). In addition, Chung et al have shown that VPB 
outgrowth was severely affected in alk8 mutants and alk8 morphants have a hypoplasic 
ventral pancreas at 3 days post fertilization (dpf) (Chung et al., 2010). However, it was 
unknown if BMP signalling was necessary for the first steps of VPB development. Thus, we 
evaluated VPB specification by analyzing the expression of ptf1a and hlxb9la (mnr2a), the 
two first VPB markers. At 32 hpf, ptf1a and hlxb9la were absent in the pancreatic region of 
alk8 mutants whereas their expression in the neural tube remained normal (Figure 1A-B and 
1E-F). However, expression of these two markers was detected a few hours later at around 38 
hpf in the pancreatic region of alk8 mutants, although in very few cells and at a reduced level 
compared to wild type siblings (Figure 1C-D and 1G-H). While hlxb9la was strongly reduced 
in the prospective VPB of alk8 mutants at 38 hpf, its expression in the dorsal pancreatic bud 
stayed unchanged (see arrowhead in Figure 1H).  In contrast to ptf1a and hlxb9la, the pan-
pancreatic marker pdx1 was not reduced in the prospective ventral bud at 30 hpf (Figure 1I-J). 
Taken together, these results indicate that BMP signalling is required for the proper activation 
of the two ventral pancreatic genes ptf1a and hlxb9la but not for the pan-pancreatic gene 
pdx1.  These data suggest that the severe pancreas hypoplasia recently reported at 72 hpf in 
the alk8 mutant is not only due to an outgrowth defect of the VPB but also results from a 
severe delay in its specification.  
 
BMP signalling is required at 20 hpf to induce ventral bud specification 
 
To determine more precisely the time-window during which the BMP signalling is required to 
specify the VPB, we blocked this pathway using the transgenic fish Tg(hsp70l:dnBmpr-GFP) 
(Pyati et al., 2005) expressing a dominant negative form of the BMP receptor fused to GFP 
under the control of the inducible heat shock promoter hsp70.  These fish were crossed with 
Tg(ptf1a:eGFP) fish and embryos from this cross were exposed to one heat shock, at 16 hpf 
(n=88), 20 hpf (n=103), 24 hpf (n=104) or 28 hpf (n=100). Expression of the dominant 
negative BMP receptor was verified after the heat shock by following the induced ubiquitous 
GFP expression, being strong after 3 hours and weak 24 hours after induction. Expression of 
ptf1a:eGFP in the ventral pancreatic region was analyzed at 48 hpf. Heat shocked embryos 
could be sorted in three kinds of phenotype: unaffected (Figure 2A), strongly reduced (Figure 
2B) and absent (Figure 2C) in the pancreatic region while other expression domains such as 
eyes and brain remained unaltered. The strongest inhibition of ptf1a:eGFP in the VPB was 
observed in Tg(hsp701:dnBmpr-GFP) embryos heat shocked at 16 or 20 hpf as 75 % of 
transgenic embryos displayed no GFP in the VPB (Figure 2D).  By contrast, heat shocking of 
embryos lacking the hsp70:dnBmpr-GFP transgene had no effect on the expression of 
ptf1a:GFP.  Blocking BMP signalling from 24 hpf in the double transgenic embryos still had 
an inhibitory effect on VPB specification but the proportion of affected embryos was smaller 
compared to 16 and 20 hpf. This proportion was further reduced when the heat shock was 
performed at 28 hpf. These data indicate that BMP activity is required from 20 hpf onward for 
the specification of VPB. In order to determine whether, in wild type embryos, the BMP 
pathway is activated in endodermal cells during this time-window, we performed an 
immunostaining at 22 hpf with anti-phosphorylated Smad1/5/8 antibody and counterstained 
with anti-Pdx1 antibody to label pancreatic cells (Figure 2E-G). Nuclear phospho-Smad 1/5/8 
staining was indeed detected in some Pdx1+ ventral cells indicating that BMP pathway is 
activate in pancreatic cells at 22 hpf. 
 
As for alk8 mutants, we examined the expression of other pancreatic markers in embryos heat 
shocked at 20 hpf. Similarly to ptf1a gene, no expression of hlxb9la could be detected in the 
VPB when analyzed at 48hpf (Figure 2H and 2I). Moreover, trypsin, a marker of the acinar 
pancreatic tissue, the major VPB derivative, is totally absent at 3 dpf (Figure 2J and 2K). 
Despite the absence of ptf1a expression at 32 hpf after BMP inhibition, pdx1 expression was 
maintained, as observed in the alk8 mutants (Figure 2L and 2M). Taken together, theses 
results indicate that activation of the BMP pathway in endodermal cells after 20 hpf is crucial 
for the induction of the early ventral pancreatic markers ptf1a and hlxb9la and for further 
acinar differentiation. 
 
bmp2a is expressed in LPM adjacent to the ventral pancreatic bud and is involved in its 
specification 
 
The LPM has been shown in vertebrates to be essential for proper specification of liver and 
pancreas (Chung et al., 2008; Manfroid et al., 2007). Zebrafish bmp2a and bmp2b have been 
both reported to be expressed in LPM at 24 hpf (Chocron et al., 2007; Chung et al., 2008). 
bmp2b is expressed in LPM since 10somites-stage and is required for hepatic specification at 
the expense of pancreatic fate while bmp2a seems activated at later stages. Thus, we 
investigated more closely the expression of bmp2a in the LPM adjacent to the prospective 
VPB when the BMP pathway is required for VPB specification. bmp2a expression starts to be 
detected in the LPM from 22 hpf at the level of the third somite, ie in the hepatopancreatic 
region (Figure 3A), and its expression increases at 24 hpf (Figure 3C) To confirm that bmp2a 
was expressed adjacent to the pancreatic region, a double in situ hybridization with a pdx1 
probe was performed. Bmp2a was expressed just next and on both sides of the pdx1 
expression domain (Figure 3B). Expression of bmp2a in LPM is also adjacent to the hepatic 
anlagen as highlighted by hhex staining (shown at 24 hpf in Figure 3C). Furthermore, bmp2a 
is expressed more ventrally compared to bmp2b (Figure 3D) and more closely to the 
prospective VPB and the hepatic bud. Thus, these results show that bmp2a is expressed at the 
correct time and place to be the BMP ligand responsible for proper ventral pancreatic bud 
specification. 
 
In order to test the role of bmp2a in VPB specification, we performed a knockdown of its 
expression using a morpholino targeting the splice donor site at the bmp2a exon 1-intron 1 
junction. The efficiency of this knockdown was checked by performing a RT-PCR on RNA 
extracted from injected embryos using primers annealing to exons 1 and 2 of bmp2a. The 
amplified cDNA was shorter in bmp2a morphants compared to control embryos and 
sequencing of this fragment revealed that the bmp2a morpholino induces a deletion of 86 bp 
in exon1 coding sequence (Figure 4D). This deletion induces a frameshift leading to a 
truncated protein of 101 aa instead of 386 aa.  When the ventral pancreatic markers ptf1a and 
hlxb9la were analyzed at 36-38 hpf in bmp2a morphants, absence or strong reduction of 
expression was noted in 69% and 73% of bmp2a morphants for these 2 genes respectively, 
(n=85 and n= 91)(Figure 4A-B). This effect was specific to the VPB and expression of 
hlxb9la in dorsal pancreatic bud remained unaffected (see arrowheads in Figure 4B). 
Expression of insulin and pdx1 was not modified at 30 hpf (data not shown). As observed in 
alk8 mutants, expression of ptf1a and hlxb9la was detected at later stages (48 hpf) in almost 
all bmp2a morphants but significantly reduced compared to control embryos (data not 
shown). Thus, these data clearly demonstrate the involvement of bmp2a in VPB development, 
its knockdown leading to a strong delay in VPB specification. 
 
As several studies have shown a role of BMP in induction of the hepatic bud (Huang et al., 
2008; Shin et al., 2007) and as bmp2a is expressed adjacent to the hhex expression domain 
(Figure 3C), we also analyzed the hepatic markers hhex and prox1 in the bmp2a morphants.  
While the expression of these two hepatic genes was still detected, their expression in the 
hepatic bud was clearly reduced in 44% of morphants (n=153) for hhex (Figure 4C) and in 
55% of morphants for prox1 (n=64). These two genes were also expressed at normal level in 
the dorsal pancreatic bud. Thus, bmp2a is not only crucial for the specification of the VPB but 
is also involved in hepatic development, albeit it is less essential than for the VPB.  
 
To verify that the delay of the VPB specification caused by bmp2a morpholino is actually due 
to the loss of BMP2a activity, we next assessed whether induced ectopic BMP expression 
could rescue this defect.  To activate BMP expression specifically at 20 hpf, we used the 
Tg(hsp70l:bmp2b) transgenic line allowing induction of bmp2b expression upon heat shock.  
bmp2a morpholinos were injected in eggs obtained from an outcross between 
Tg(hsp70l:bmp2b) and wild type fish. Then, injected embryos were heat shocked at 20 hpf 
and hlxb9la expression was analyzed by ISH at 38 hpf. Identification of transgenic and non-
transgenic embryos was performed after hlxb9la staining by genotyping. Tg(hsp70l:bmp2b) 
embryos also display loss of hlxb9la expression in rhombomeres 5 and 6 (see arrowheads in 
Figure 4E and 4F). The rescue of hlxb9la expression in bmp2a morphants is shown in Figure 
4G. The percentage of embryos exhibiting absence of hlxb9la expression in the pancreatic 
region was drastically reduced in the transgenic embryos (12%, n=32) compared to the non 
transgenic embryos (31%, n=38).  Also, the percentage of embryos with normal hlxb9la 
expression in the VPB was significantly higher in the transgenic (50%) compared to non 
transgenic (21%) embryos. Thus, overexpression of bmp2b at 20 hpf can partially rescue the 
knockdown of bmp2a and indicates that the delay in VPB specification caused by the bmp2a 
morpholino is specific.  
 
fgf10 and 24 are specifically involved in ventral pancreatic specification 
 
As the specification of the ventral pancreas and the development of the neighbouring hepatic 
bud both rely on bmp2a, other extrinsic factors must determine the choice between the 
pancreatic or hepatic fate. We recently reported by morpholino knockdown experiments that 
fgf10 acts redundantly with fgf24 to control the formation of the pancreatic exocrine tissue 
(Manfroid et al., 2007). However, the role of these two FGF ligands on hepatic specification 
has not been investigated. Therefore, we generated fgf10; fgf24 compound mutants and 
examined in detail the development of the entire hepatopancreatic region. Analysis of trypsin 
and transferin (tfa) expression at 3 dpf indicated a complete lack of the pancreatic exocrine 
tissue in the double mutants while the liver was not reduced (Figure 5A), confirming our 
previous knockdown data. The absence of pancreatic exocrine tissue was due to a defect in 
VPB specification as expression of ptf1a and hlxb9la was not detected in most double fgf10; 
fgf24 mutants at 48 hpf (Figure 5B and data not shown). As the VPB also gives rise to the 
pancreatic ducts, their formation was next analyzed in the compound mutants. 
Immunolabelling with Prox1, HNF4 and 2F11 antibodies revealed complete lack of the 
extrapancreatic duct (EPD) connecting the pancreas to the intestine in the mutants at 50 hpf 
(red arrowhead). Indeed, while the 2F11+ ductal cells delineating the extrahepatic duct (EHD) 
still make the junction between the hepatic bud and intestine in the mutants, extrapancreatic 
ductal cells could not be detected between the pancreatic islet, derived from the dorsal 
pancreatic bud (also 2F11+), and the intestine (Figure 5D). In addition, the hepatic domain 
appeared posteriorly expanded towards the pancreatic endocrine islet in all mutants examined 
(green arrowheads) (n=6 for wild type embryos and n=8 for mutant embryos). Indeed, while 
the distance from the anterior limit of the hepatic bud to the islet did not significantly change 
(125 μm in wild type embryos and 127 μm in mutants, yellow dotted lines), the length of the 
hepatic domain increased (108 μm in mutants compared to 75 μm in wild type embryos, 
white dotted lines). When the double fgf10; fgf24 mutants were analyzed at 3 dpf, no 
pancreatic acinar cell (Prox1+) could be detected around the islet as well as no intra- and 
extra- pancreatic ducts (Figure 5E and F). In addition, masses of ectopic hepatocyte-like 
(Prox1+/HNF4+/2F11-) cells and biliary-like cells (Prox1+/HNF4-/2F11+ cells) were 
observed contiguous to the hepatopancreatic duct remnants and also in direct contact with the 
gut (Figure 5E and F). As ectopic tfa expression was also noticed in this region (see white 
arrowhead in Figure 5A), this supports ectopic hepatic differentiation occurring posterior to 
the hepatic domain. Thus, all these data demonstrate a complete lack of pancreatic acinar and 
pancreatic ductal cells in the fgf10; fgf24 mutants, while hepatic cell differentiation seems 
increased. These results led us to examine whether, in the double mutants, specification of the 
hepatic bud was favoured at the expense of the ventral pancreas. To that goal, we examined 
the expression of the hepatic marker prox1 and of the pancreatic marker pdx1 at 29 hpf i.e. 
just prior to the initiation of ventral pancreas specification (Figure 5C). Interestingly, pdx1 
labelling in the ventral aspect of the pancreatic domain was dramatically reduced in all the 
double mutants while the prox1+ hepatic domain was expanded posteriorly and reached the 
dorsal pancreas (green arrowheads, n=4). This observation suggests that, in the absence of 
FGF10/FGF24 signalling, hepatic progenitors are specified at the expense of the ventral 
pancreatic progenitors. 
As bmp2a, fgf24 and fgf 10 are involved in specification of the VPB, we finally tested 
whether cross-regulation occurs between these extrinsic factors. As fgf10 expression starts in 
the LPM about 5 hours after the onset of bmp2a expression (Manfroid et al., 2007), the 
activation of bmp2a cannot be controlled by fgf10.  As previously reported, the fgf24 gene 
displays a dynamic expression pattern, being expressed in the gut endoderm before 24 hpf, 
then endodermal expression progressively decreases at the level of the pancreas while it 
appears in the adjacent pancreatic LPM. Expression of bmp2a was not modified in fgf24 
mutants at 24 hpf (data no shown). Inversely, fgf24 and fgf10 expression was analyzed in 
bmp2a morphants. In order to accurately discern fgf24 expression in the endoderm and in the 
LPM, double in situ hybridization was performed with fgf24 and pdx1 probes. Comparison of 
wild type and bmp2a morphant embryos at 32 hpf revealed that the expression of fgf24 is 
strongly decreased in the pancreatic LPM while the level in the endoderm remains high 
(Figure S1A). In contrast, fgf10 expression in the LPM was not affected in bmp2a morphants 
(Figure S1B).  All these data indicate that bmp2a acts not only on the endoderm but also on 





Conflicting data have been reported on the effect of BMP and FGF signals on pancreas 
development either showing a negative effect (Chung et al., 2008; Deutsch et al., 2001; Rossi 
et al., 2001; Shin et al., 2007; Spagnoli and Brivanlou, 2008; Tehrani and Lin, 2011) or a 
positive effect (Kumar et al., 2003; Manfroid et al., 2007; Wandzioch and Zaret, 2009).  
Studies on mouse embryonic explants have first indicated that these two signalling pathways 
act on endodermal progenitors to favour hepatic differentiation while restricting formation of 
pancreatic cells (Rossi et al., 2001).  Such role of the BMP pathway has also been confirmed 
in zebrafish; indeed, BMP2b secreted from the LPM around 14 hpf acts on endodermal cells 
to induce hepatic fate at the expense of pancreas (Chung et al., 2008). In the present study, we 
show that, a few hours later at around 20-24 hpf, the BMP pathway plays a different role and 
is actually essential for the specification of the ventral pancreatic bud.  Furthermore, we 
identify BMP2a as a major BMP ligand responsible for this induction process. Similarly, FGF 
signalling has been shown to play a crucial role in development of liver in vertebrate (Deutsch 
et al., 2001) and notably in zebrafish embryos between 18 and 22 hpf, i.e. just before hepatic 
specification (Shin et al., 2007).  Here, we demonstrate that fgf10 and fgf24, also expressed in 
the LPM around 26 hpf and required for ventral pancreas specification, impair hepatic 
development. Finally, we show that bmp2a positively regulates fgf24 expression in the LPM. 
In conclusion, our data underscore the importance of the developmental stage in the response 
to these extrinsic signals.   
 
 
BMP signalling is crucial for ventral pancreatic specification 
 
A recent analysis of the alk8 zebrafish mutants has revealed an increase of endocrine 
pancreatic -cells but also a severe hypoplasy of the ventral pancreas (Chung et al., 2010). In 
this study, we have focused our analyses on the first steps of ventral pancreatic bud 
development by analyzing three early pancreatic markers, pdx1, ptf1a and hlxb9la. We show 
that these three pancreatic regulatory genes are differently controlled in response to BMP 
signalling. Indeed, while pdx1 was not significantly affected in the alk8 mutants, expression 
of ptf1a and hlxb9la was not detected at 32 hpf and strongly reduced after 38 hpf in these 
mutants. A similar regulation was observed when BMP pathway was disrupted by two other 
means: first, by blocking BMP receptors after 20 hpf by using the Tg(hsp70l:dnbmpr-GFP) 
line, secondly, by the knockdown of bmp2a. 
 
The delay in the formation of the ptf1a+ cells was longer after induction of the dominant 
negative receptor dnBMPR-GFP than in alk8 mutants and bmp2a morphants (a 16 hours delay 
compared to 6 hours). Such differences in phenotype severity are probably due to 
compensation by others BMP receptors I and other BMP ligands expressed at later stages.  
bmp2a expression in the LPM coincides in timing and space with the requirement of BMP for 
ventral pancreas specification.  It is interesting to remind that its paralog, bmp2b, expressed a 
few hours before, triggers an opposite action on pancreas specification, indeed favouring 
hepatic fate at the expense of pancreatic fate.  This is not due to different biological activities 
of the two BMP2 proteins, as bmp2a morphant defects can be partially rescued by bmp2b 
overexpression, but rather results from a difference in their timing of expression. We can 
speculate that, after the genome duplication that occurred early during teleost evolution, each 
copy of the ancestral  bmp2 gene retained distinct regulatory sequences driving expression in 
the LPM either at early (for bmp2b) or later (for bmp2a) developmental stages.  As in 
zebrafish, the critical stages of liver specification precede ventral pancreas specification, the 
role of the two bmp2 paralogs were split, bmp2b acting on liver specification and bmp2a 
acting on ventral pancreas specification and on the maintenance of hepatic genes hhex and 
prox1.   
 
fgf10 and 24 specify the VPB at the expense of the hepatic fate 
 
One important finding of our study is the role fgf10 and fgf24 in the induction of ventral 
pancreas while they restrict hepatic competence. Activation of ptf1a and hlxb9la genes in 
endoderm is not detected at 32 hpf in the double fgf10;fgf24 mutants and the pdx1+ domain 
becomes significantly reduced while the prox1+ hepatic domain extends posteriorly. Only a 
delay in ptf1a and hlxb9la endodermal expression was observed either in fgf24 homozygous 
mutants or in some double heterozygotes (data not shown), but expression of these two genes 
reappears later around 44 hpf (data not shown). This indicates that a correct level of FGF is 
required for proper timing of ventral pancreas specification. At 3 dpf, the fgf10-/-; fgf24-/- 
larvae possess only the pancreatic endocrine islet, which is derived from the dorsal bud, and 
no pancreatic exocrine tissue. The liver bud in these mutant larvae is apparently normal but 
ectopic masses of hepatocytes develop in the endoderm just posterior to the liver, near the 
remnant of the hepatopancreatic ducts and closed to the junction with the intestine. The actual 
origin of these hepatocytes is unclear; they may derive from the posterior extension of the 
prox1+ hepatic domain observed at 30 hpf (Figure 3C). Two zebrafish studies have recently 
described defects highly similar to the fgf10; fgf24 mutant phenotype as they showed that the 
endoderm posterior to the hepatic domain, corresponding to the prospective intestinal bulb 
and pancreas, can give rise to ectopic hepatocytes upon Wnt overexpression (Poulain and 
Ober, 2011; Shin et al., 2011). Interestingly, this hepatic competence can be induced by Wnt 
overexpression at 26 hpf, thus following liver specification in the hepatic progenitor domain 
at 22 hpf. Moreover, it is negatively regulated with time by FGF signalling (Shin et al., 2011) 
and fgf10a (here referred to as fgf10) was shown to be partially responsible of this inhibitory 
effect. Our present data indicate that the combined loss of fgf10 and fgf24, both genes being 
expressed in the LPM after liver specification, is sufficient to trigger hepatic cell 
differentiation posterior to the normal hepatic domain without artificial Wnt overexpression. 
Whether Wnt signalling is activated in the fgf10; fgf24 compound mutants remains to be 
elucidated.  
 
Our data showing the ability of FGF signalling to induce pancreatic fate versus hepatic fate 
contrast drastically with previous data on mouse embryonic explants demonstrating the 
opposite effect of FGF (Deutsch et al., 2001).  This difference does not seem to be due to 
intrinsic biological activities of FGF10 and FGF24 protein ligands as the phenotype of the 
fgf10;fgf24 mutant can be almost recapitulated in wild type zebrafish embryos treated with 
FGF inhibitor SU5402 between 24 hpf and 48 hpf (data not shown and (Manfroid et al., 
2007)).  In contrast, if FGF signalling is blocked at earlier stage (i.e. from 18 hpf onward), 
liver specification is disrupted (Shin et al., 2007). This again underscores the importance of 
developmental stage in the response to extrinsic factors.   
 
From data of this and other zebrafish studies, we can build a model where hepatic versus 
pancreatic commitment is controlled by the sequential action of distinct extrinsic factors 
(Figure 6). First, bmp2b expressed in the LPM from 14 hpf promotes hepatic fate at the 
expense of pancreatic fate notably through a down-regulation of pdx1 in gut endoderm 
(Chung et al., 2008; Shin et al., 2007). Then, around 18-22 hpf, a FGF signal, whose exact 
identity is still unknown, is required to activate hhex and prox1 genes in hepatoblasts (Shin et 
al., 2007).  Activation of these two hepatic genes also necessitates Wnt2bb expression from 
the LPM from 22 hpf (Ober et al., 2006). BMP2A is also secreted from that stage to allow 
activation of ptf1a and hlxb9la genes in the VPB and to maintain high expression level of 
hhex and prox1 in hepatoblasts. Secretion of FGF10 and FGF24 from around 24-26 hpf is 
essential for the onset of ptf1a and hlxb9la expression determining ventral pancreatic bud. In 
the absence of these two FGF ligands, the prox1/hhex+ hepatic anlagen expands posteriorly at 
the expense of pdx1+ cells. Finally, our results also reveal that bmp2a stimulates fgf24 
expression in the pancreatic LPM. As fgf24 expression in the LPM, reflecting proper 
pancreatic LPM patterning (Manfroid et al., 2007), is important for VPB specification, this 
thereby demonstrates that cross-talks between BMP and FGF pathways contribute to 
coordinated liver and pancreas development. 
 
 
Materials and Methods 
 
Embryos 
Zebrafish (Danio rerio) were raised and cared for according to standard protocols 
(Westerfield, 1995). Wild type embryos from the AB strain were used and staged according to 
Kimmel (Kimmel et al., 1995). We used the following mutant and transgenic lines:  laftm110b 
(Mintzer et al., 2001), Tg(hsp70l:dnBmpr-GFP) (Pyati et al., 2005), Tg(ptf1a:eGFP) 
(Godinho et al., 2007) and Tg(hsp70l:bmp2b) (Chocron et al., 2007). 
 
Heat shock conditions 
Embryos were heat shocked at various stages by transferring them into a pre-warmed falcon 
containing egg water in a water bath.. Tg(hsp70l:dnBmpr-GFP) embryos were heat shocked 
for 30 minutes at 40°C; Tg(hsp70l:bmp2b) embryos for 30 minutes at 37°C. After heat shock, 
embryos were transferred at 28°C, and then were harvested between 30 and 72 hpf. 
Hemizygous Tg(hsp70l:dnBmpr-GFP) embryos were sorted 3 hours after heat shock based on 
GFP positive expression. Hemizygous Tg(hsp70l:bmp2b) embryos were tested for presence of 
the hsp70l:bmp2b transgene by PCR using genomic DNA after in situ hybridization, using the 
primers previously used by Shin et al (Shin et al., 2007). In our hands, a nested PCR was 
needed and the following primers were used: 5’-GCAAAAGGCCAGGAACCGTAA-3’ and 
5’- GCACACAGCCCAGCTTGGAGC-3’. 
 
Whole-mount in situ hybridization and immunochemistry 
Visible in situ hybridization (ISH) was performed as described (Hauptmann and Gerster, 
1994). Fluorescent labeling was performed as described (Mavropoulos et al., 2005). 
The riboprobes used were ptf1a (Zecchin et al., 2004), hlxb9la (Wendik et al., 2004), trypsin 
(Biemar et al., 2001), pdx1 (Milewski et al., 1998) bmp2a (Thisse and Thisse, 2005), tfa 
(Mudumana et al., 2004), prox1 (Glasgow and Tomarev, 1998) and hhex (Ho et al., 1999). 
Whole-mount immunohistochemistry was described in (Dong et al., 2007). We used the 
following antibodies: polyclonal rabbit anti-Prox1 (1:1000, Chemicon), polyclonal rabbit anti-
phospho-Smad (1:200, Cell Signaling), polyclonal guinea pig against zebrafish Pdx1 (1:200, 
gift from C. Wright), polyclonal goat anti-HNF4 (1:100, Santa Cruz Biotechnology), 
monoclonal mouse 2F11 (Crosnier et al., 2005) (1:1000, gift from J. Lewis) and fluorescently 
conjugated Alexa antibodies (Molecular Probes).  
Fluorescent images were acquired with a Leica SP2 or Olympus FluoView FV1000 confocal 
microscopes and 3D Blend projections were performed with the Imaris software (Bitplane). 
 
Injection of morpholino antisense oligonucleotides 
 
Morpholino oligonucleotides (MO) were purchased by Gene Tools, LLC. Each MO was 
resuspended in Danieau’s solution at the stock concentration of 8  μg/μl. For injections, they 
were further diluted in Danieau’s solution at 4ng/nl with 0.5% Rhodamine dextran to check 
injection efficiency. The splice inhibition MO bmp2a 
(AGTAAACACTTGCTTACCATCATGG) targets the exon1-intron1 boundary. 
 
Control of the morpholino efficiency 
Zebrafish embryos were injected at one-cell stage with Mo Bmp2a (4ng/embryo) and mRNAs 
were extracted at 30 hpf. RT-PCR were performed on 1 μg of mRNAs. The primers used for 
PCR amplification were the followings: bmp2a exon 1 (upstream primer; 5’-
GGCTCCAGTGGACTCGTTCCTCA-3’), bmp2a exon 2 (downstream primer, 5’-
CTCCTGAAGAGAACCGGACGGCCT-3’) and PCR cycles were performed as follows: 40 
cycles of 30 sec at 94°C, 30 sec at 55°C and 30 sec at 72°C, followed by a final 7-min 
extension at 72°C. Amplified cDNAs were analyzed by gel electrophoresis and sequencing. 
Genotyping 
 
Genotyping was performed on genomic DNA extracted from adult tails or tails obtained from 
embryos processed through in situ hybridization or immunohistochemistry. The ikarus 
mutation in the fgf24 locus generates a restriction site for the AccI endonuclease. The PCR 
fragment obtained with forward 5'-CTGTCAGTCCCACAGCAGTGGACCA-3' and reverse 
5'-CCATGTAGATTTTATTACATGTAGGT-3' primers (615 pb) digested by AccI produces 
two fragments (185 and 430 pb) in the mutant. The daedalus mutation in fgf10 generates a 
SNP that was identified by the TaqMan SNP Genotyping Assays (Applied Biosystem). The 
region encompassing the mutation was amplified with the forward primer dae-SNp1F 5'-
CCGAGCTCCAGGACAATGTG-3' and reverse primer dae-SNp1R 5'-
GCAGGACAGACGGAACCA-3'. Allelic discrimination was performed by dae-SNp1V2 
VIC primer 5'-CCCTTAGTCACTTTCCATTT-3' (wild type allele) and dae-SNp1M2 FAM 
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Decrease in BMP signalling leads to a delay in VPB specification and to a reduction in 
ptf1a+ and hlxb9la+ VPB progenitors 
(A and B) Ventral view of ptf1a expression in wild type (wt) sibling compared to alk8 mutant 
(alk8-/-) at 32 hpf. (C and D) Lateral view of ptf1a expression in wt and alk8 mutant at 36-38 
hpf. (E-J) Lateral view of hlxb9la expression in wt and alk8 mutant at 32 hpf (E and H)and 
36-38 hpf. (I andJ). Lateral view of pdx1 expression in wt and alk8 mutant. White and black 
brackets, white dot circle underlines the ventral pancreatic bud (VPB); white dot brackets 
indicate the prospective ventral pancreatic bud; white arrowheads indicate the dorsal 
pancreatic bud (DPB). 
 
Figure 2 
BMP signalling is essential at 20 hpf for VPB specification 
(A-C, H-M) Embryos obtained from outcrossing a hemizygous Tg(hsp70l:dnBmpr-GFP) 
zebrafish with homozygous Tg(ptf1a:eGFP) were heat shocked at 20hpf and harvested at 30 
hpf (L and M) 48 hpf (A-C, H-I) and 3 dpf (J,K) and examined for ptf1a:eGFP fluorescence 
(A-C), hlxb9la (H and I), trypsin (J and K), ptf1a and pdx1 (L and M) expression. (D) Graph 
quantifying ptf1a:GFP expression in wild type (wt) and Tg(hsp70l:dnBmpr-GFP) heat 
shocked embryos at 16 hpf, 20 hpf, 24 hpf and 28 hpf. Data are presented as the percentage of 
embryos displaying normal (white), reduced (orange), or absent (red) ptf1a:GFP fluorescence. 
(E-G) Confocal z-lane showing activation of the BMP pathway in pancreatic cells revealed by 
immunostaining with anti-pSmad 1/5/8 (green) (E) and anti-Pdx1 (red) (H) antibodies. 
Double pSmad 1/5/8 + and Pdx1+ cells are observed on the merge picture (G). White brackets 
underline the VPB. DPB, dorsal pancreatic bud; s, somite. 
 
Figure 3 
bmp2a is expressed in the LPM adjacent to the hepatopancreatic endoderm at 22 hpf 
(A)Lateral view showing bmp2a expression in the LPM starting at 22 hpf . The square shows 
a close-up of the region pointed by the dot-lines. (B) bmp2a (green) and pdx1 (red) expression 
analyzed by fluorescent whole-mount in situ hybridization at 22 hpf. The transverse sections 
were analyzed by confocal microscopy. (C) bmp2a (green) and hhex (red) expression 
analyzed at 24 hpf with. (D) bmp2a (green) and bmp2b (red) expression comparison at 24 hpf. 
The images of transverse sections are flat stacking of several consecutive optical sections. 
TO-PRO-3 (blue) labels nuclei. Yellow and white dots delineate the LPM and the notochord 
(nc), respectively. FB, Fin bud. 
 
Figure 4 
Knockdown of bmp2a represses VPB specification 
(A-C) Analysis of ventral pancreatic and hepatic markers in control morphants (left column) 
and in bmp2a morphants (right columns) by in situ hybridization. (A) Laterial view of ptf1a 
expression at 36-38hpf. (B) Laterial view of hlxb9la expression at 36-38hpf.. (C)Ventral view 
of hhex expression at 30 hpf. Percentage represents the proportion of morphants exhibiting a 
reduction (middle column) or an absence (right column) of gene expression. (D) Gel 
electrophoresis after RT-PCR (left) and sequencing result (right) illustrating the RNA splicing 
defects caused by the bmp2a morpholino in injected embryos.. The sequence of the amplified 
bmp2a fragment was aligned with wt bmp2a cDNA and revealed a 86bp deletion in exon1. 
Black line underlines the binding site of the bmp2a morpholino. Red arrow shows the junction 
between exon 1 and intron 1. (E and F) Lateral view of hlxb9la expression at 38 hpf in wt and 
Tg(hsp70l:bmp2b) in uninjected embryos (E) or in bmp2a morphants (F). Embryos were heat 
shocked at 20 hpf. (G) hlb9la expression in wt and Tg(hsp70l:bmp2b) embryos injected with 
MO bmp2a, heat shocked at 20 hpf and fixed at 38 hpf. Data are presented as the percentage 
of embryos displaying normal (white), reduced (orange), or absent (red) expression of 
hlxb9la. Black brackets underline the VPB; black arrowheads indicate the dorsal pancreatic 
bud (DPB); white arrows indicate rhombomeres 5 and 6 localisation. HB, hepatic bud. 
 
Figure 5 
Absence of VPB cells and ectopic hepatic cells in fgf10; fgf24 compound mutants 
(A) Dorsal view of transferrin (tfa) and trypsin (try) expression, comparing wild type (wt) and 
fgf10; fgf24 mutants at 3dpf. (B) Dorso-lateral view of ptf1a expression comparing wt and 
double mutants at 48 hpf. (C) Confocal projection of the pdx1 and prox1 expression domains 
at 29 hpf showing the severe decrease of pdx1 in the anterior part of the pancreatic region and 
the extension of prox1 in fgf10; fgf24 mutants (green arrowheads). (D-F) Immunolabelling of 
the hepatopancreatic region with 2F11, Prox1 and HNF4 in wild type and fgf10; fgf24 
double mutants. (D) At 50 hpf, the ventral pancreas and the EPD are absent (red arrow) in 
fgf10; fgf24 mutants (confocal projections). (E and F) Morphology and differentiation of the 
hepatopancreatic ducts connecting the pancreas and liver to the intestine in fgf10; fgf24 
double mutants at 3 dpf (E, 3D Blend projection and F, z-planes). Black arrows indicate 
pancreas and VPB; white arrow head indicates ectopic tfa expression; islet, endocrine islet; 
EHD, extrahepatic duct; EPD, extrapancreatic duct; GB, gall bladder. Scale bar = 20 μm. 
 
Figure 6 
Model for the role of BMP and FGF pathways in hepatopancreatic patterning 
Bipotential endodermal progenitors, shown in the center of the scheme, can give rise to liver 
and pancreatic cells through the consecutive action of extrinsic signals secreted from the 
lateral mesoderm. Hepatic specification is determined by hhex and prox1 expression while 
pdx1, ptf1a and hlxb9la are markers of pancreatic cell commitment.  
 
